Gateway Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$694K Sell
1,385
-293
-17% -$141K 0.04% 389
2026
Q1
$824K Buy
1,678
+1,331
+384% +$722K 0.03% 420
2025
Q4
$201K Buy
+347
New +$196K 0.02% 449

Other funds holding TMO

Gateway Wealth Partners's TMO Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $141K and leaving 1,385 shares worth $694K. The position accounts for 0.04% of the portfolio, ranked #389.

Gateway Wealth Partners first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $824K in Q1 2026. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Gateway Wealth Partners held 1,385 shares of Thermo Fisher Scientific worth $694K as of Q2 2026.
  • Gateway Wealth Partners sold 293 Thermo Fisher Scientific shares in Q2 2026, an estimated $141K.
  • Thermo Fisher Scientific made up 0.04% of Gateway Wealth Partners's portfolio in Q2 2026, its #389 holding.
  • Gateway Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Gateway Wealth Partners's Thermo Fisher Scientific position peaked at $824K in Q1 2026.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.